📣 VC round data is live. Check it out!
- Public Comps
- Enhabit
Enhabit Valuation Multiples
Discover Enhabit's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Oncology Institute, InnovAge, Cross Country Healthcare, LNA Sante and more.
Enhabit Overview
About Enhabit
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
Founded
2014
HQ

Employees
10.7K
Website
Sectors
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialEnhabit Financials
Enhabit reported last 12-month revenue of $1B and EBITDA of $107M.
In the same LTM period, Enhabit generated $522M in gross profit, $107M in EBITDA, and $10M in net income.
Revenue (LTM)
Enhabit P&L
In the most recent fiscal year, Enhabit reported revenue of - and net income of -.
Financial data powered by Morningstar, Inc.
Enhabit Stock Performance
Enhabit has current market cap of $707M, and enterprise value of $1B.
Market Cap Evolution
Enhabit's stock price is $13.80.
Enhabit share price increased by 43.2% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $707M | 0.0% | - | -2.1% | 43.2% | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEnhabit Valuation Multiples
Enhabit trades at 1.1x EV/Revenue multiple, and 10.6x EV/EBITDA.
EV / Revenue (LTM)
Enhabit Financial Valuation Multiples
As of June 2, 2026, Enhabit has market cap of $707M and EV of $1B.
Enhabit has a P/E ratio of 67.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Enhabit Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Enhabit Margins & Growth Rates
Enhabit Margins
Enhabit Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Enhabit Operational KPIs
Enhabit's Rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Enhabit's Rule of X is 15% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Enhabit Competitors
Enhabit competitors include Oncology Institute, InnovAge, Cross Country Healthcare, LNA Sante, Propel Funeral Partners, Oceania Healthcare, Omada Health, Ship Healthcare Holdings, Summerset Group Holdings and Eureka Group Holdings.
Most Enhabit public comparables operate across Long-Term Care.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.1x | 1.0x | (44.5x) | (103.5x) | |||
| 1.1x | 1.0x | 27.5x | 11.2x | |||
| 0.3x | 0.3x | 11.3x | 11.4x | |||
| 1.3x | 1.2x | 7.5x | 8.1x | |||
| 2.9x | 2.8x | 12.3x | 11.3x | |||
| 3.1x | 3.1x | 16.9x | 15.8x | |||
| 3.5x | 3.1x | 138.8x | 80.5x | |||
| 0.2x | 0.2x | 4.1x | 4.2x | |||
This data is available for Pro users. Sign up to see all Enhabit competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Enhabit
Enhabit has acquired 2 companies to date.
Last acquisition by Enhabit was on December 1st 2022. Enhabit acquired Southwest Florida Homecare for undisclosed valuation.
Latest Acquisitions by Enhabit
| Description | Southwest Florida Homecare is a Fort Myers-based agency delivering skilled nursing, physical therapy, occupational therapy, and personal care services to homebound patients. Licensed by Florida's Agency for Health Care Administration, it serves Lee, Collier, and Charlotte counties with 24/7 on-call support. | Caring Hearts Hospice delivers end-of-life care services to patients with terminal illnesses through locations in multiple U.S. states. Services encompass pain management, emotional support, medical equipment provision, and therapies such as physical and occupational rehabilitation. Medicare-certified operations ensure compliance with federal standards, serving communities in Texas, Louisiana, and beyond with interdisciplinary teams of nurses, physicians, and counselors. |
| HQ Country | ||
| HQ City | Fort Myers, FL | Houston, TX |
| Deal Date | 1 Dec 2022 | 1 Oct 2022 |
| Valuation | undisclosed | $14M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Enhabit acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Enhabit
| When was Enhabit founded? | Enhabit was founded in 2014. |
| Where is Enhabit headquartered? | Enhabit is headquartered in United States. |
| How many employees does Enhabit have? | As of today, Enhabit has over 10K employees. |
| Who is the CEO of Enhabit? | Enhabit's CEO is Barbara A. Jacobsmeyer. |
| Is Enhabit publicly listed? | Yes, Enhabit is a public company listed on NYSE. |
| What is the stock symbol of Enhabit? | Enhabit trades under EHAB ticker. |
| When did Enhabit go public? | Enhabit went public in 2022. |
| Who are competitors of Enhabit? | Enhabit main competitors include Oncology Institute, InnovAge, Cross Country Healthcare, LNA Sante, Propel Funeral Partners, Oceania Healthcare, Omada Health, Ship Healthcare Holdings, Summerset Group Holdings, Eureka Group Holdings. |
| What is the current market cap of Enhabit? | Enhabit's current market cap is $707M. |
| What is the current revenue of Enhabit? | Enhabit's last 12 months revenue is $1B. |
| What is the current revenue growth of Enhabit? | Enhabit revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Enhabit? | Current revenue multiple of Enhabit is 1.1x. |
| What is the current EBITDA of Enhabit? | Enhabit's last 12 months EBITDA is $107M. |
| What is Enhabit's EBITDA margin? | Enhabit's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Enhabit? | Current EBITDA multiple of Enhabit is 10.6x. |
| What is the current FCF of Enhabit? | Enhabit's last 12 months FCF is $70M. |
| What is Enhabit's FCF margin? | Enhabit's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Enhabit? | Current FCF multiple of Enhabit is 16.2x. |
| How many companies Enhabit has acquired to date? | As of June 2026, Enhabit has acquired 2 companies. |
| What was the largest acquisition by Enhabit? | $14M acquisition of Caring Hearts Hospice on 1st October 2022 was the largest M&A Enhabit has done to date. |
| What companies Enhabit acquired? | Enhabit acquired Caring Hearts Hospice and Southwest Florida Homecare. |
| In how many companies Enhabit has invested to date? | Enhabit hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Enhabit
Lists including Enhabit
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
